Rationale: Much is known about the acute infective process of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease …

Methods Patients were prospectively screened and recruited from The Ottawa Hospital
administrative registry and from our study website (https://omc. ohri. ca/left/) in sequential …

Purpose Few data are currently available on persistent symptoms and late organ damage in
patients who have suffered from COVID-19. This prospective study aimed to evaluate the …

Background Comorbidities play a key role in severe disease outcomes in COVID-19
patients. However, the literature on preexisting respiratory diseases and COVID-19 …

The enduring impact of COVID-19 on patients has been examined in recent studies, leading
to the description of Long-COVID. We report the lasting symptom burden of COVID-19 …

Background The coronavirus disease (COVID-19) pandemic has already affected more than
400 million people, with increasing numbers of survivors. These data indicate that a myriad …

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

Introduction Prospective and longitudinal data on pulmonary injury over one year after acute
coronavirus disease 2019 (COVID-19) are sparse. We aim to determine reductions in …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the coronavirus disease 2019 (COVID-19) pandemic that has resulted in …

Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …